Clinical Trials Directory

Trials / Unknown

UnknownNCT03129412

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

The Clinical Curative Efficacy and Side Effect of Oligo-metastases Nasopharyngeal Carcinoma Patients Received Radical Radiation for Primary Tumors and Treatments for Metastatic Lesions

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Oligo-metastases NPC patients received radiation for primary tumors and treatments for metastatic lesions.

Detailed description

The patients enrolled will received 4-6 cycles chemotherapy at first.Then, radical radiotherapy for nasopharyngeal tumors and local treatments for oligometastatic lesions will assigned to those patients. The efficacy and side-effect will be evaluated and analyzed.

Conditions

Interventions

TypeNameDescription
RADIATIONradical radiotherapyradical radiotherapy for primary tumors were given. Appropriate treatments for olio-metastatic lesions will be assigned to those who got PR,SD after chemotherapy.

Timeline

Start date
2017-04-14
Primary completion
2023-04-23
Completion
2025-04-23
First posted
2017-04-26
Last updated
2020-09-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03129412. Inclusion in this directory is not an endorsement.

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions (NCT03129412) · Clinical Trials Directory